Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III results with Metvix PDT for primary BCC reported as positive

Jan. 10, 2001

Novogen begins second phase I trial of anticancer agent in Australia

Jan. 9, 2001

Phytopharm reports promising clinical trial results for P-54 in colorectal cancer

Jan. 9, 2001

Matrix completes NDA filing for IntraDose injectable gel

Jan. 9, 2001

Wide series of CDK/cyclin inhibitors developed at Pharmacia

Jan. 9, 2001

FDA issues nonapprovable letter for Atragen; company plans to continue development

Jan. 9, 2001

Elan prepares launch of Myocet in Europe

Jan. 8, 2001

Anti-EGF MAb produces clinical, biochemical improvement in patient with Menetrier's disease

Jan. 8, 2001

Topically applied CDK2 inhibitor prevents chemotherapy-induced hair loss

Jan. 8, 2001

NeoOncoRx to acquire worldwide rights to novel class of anticancer agents

Jan. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...